Literature DB >> 7495295

Peripheral blood leukocyte grafts that induce human to mouse graft-vs.-host disease reject allogeneic human skin grafts.

W Huppes1, G Hoffmann-Fezer.   

Abstract

Allogeneic graft-versus-host disease is characterized by skin, gut, and bile duct destruction by relatively few donor type lymphocytes. In contrast, we can now show that human-to-mouse xenogeneic graft-versus-host disease is characterized by vasculitis and tumor-like infiltrations of the murine lymphohemopoietic organs with many human CD25+, HLA-DR+, CD4+ lymphoblasts. Using the technique of serial transplantation, it appears that at least 90% of the human lymphoblasts were unreactive to murine tissues. It is demonstrated consistently that the donor type lymphoblasts induced typical allogeneic rejection of distantly located full thickness human unmatched fetal skin grafts. The fact that the human grafts show primary immune responses in vivo indicates that the graft-versus-host disease murine model may be suitable for vaccination studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495295      PMCID: PMC1869952     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction.

Authors:  D W van Bekkum; S Knaan
Journal:  J Natl Cancer Inst       Date:  1977-03       Impact factor: 13.506

Review 2.  The scid mouse: mutation in a DNA repair gene creates recipients useful for studies on stem cells, lymphocyte development and graft-versus-host disease.

Authors:  R A Phillips; D E Spaner
Journal:  Immunol Rev       Date:  1991-12       Impact factor: 12.988

3.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?

Authors:  P Matzinger; M J Bevan
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

4.  Phenotypic and functional studies of human peripheral blood lymphocytes engrafted in scid mice.

Authors:  E Simpson; J Farrant; P Chandler
Journal:  Immunol Rev       Date:  1991-12       Impact factor: 12.988

5.  Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors.

Authors:  G Hoffmann-Fezer; B Kranz; C Gall; S Thierfelder
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

6.  Acute human vs. mouse graft vs. host disease in normal and immunodeficient mice.

Authors:  W Huppes; B De Geus; C Zurcher; D W Van Bekkum
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

7.  Cytokine dependence of human to mouse graft-versus-host disease.

Authors:  W Huppes; H Fickenscher; B A 'tHart; B Fleckenstein
Journal:  Scand J Immunol       Date:  1994-07       Impact factor: 3.487

8.  Transfer of a functional human immune system to mice with severe combined immunodeficiency.

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

9.  scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair.

Authors:  K A Biedermann; J R Sun; A J Giaccia; L M Tosto; J M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

10.  Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.

Authors:  M Tary-Lehmann; A Saxon
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  4 in total

1.  Experimental production and modulation of human cytotoxic dermatitis in human-murine chimeras.

Authors:  M Christofidou-Solomidou; S M Albelda; F C Bennett; G F Murphy
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

2.  Update of humanized animal disease models in studying Graft-versus-host disease.

Authors:  Feng Huang; Feng Lin Cao; Song Guo Zheng
Journal:  Hum Vaccin Immunother       Date:  2018-09-05       Impact factor: 3.452

Review 3.  Human allograft rejection in humanized mice: a historical perspective.

Authors:  Michael A Brehm; Leonard D Shultz
Journal:  Cell Mol Immunol       Date:  2012-02-13       Impact factor: 11.530

4.  Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.

Authors:  A G Murray; J S Schechner; D E Epperson; P Sultan; J M McNiff; C C Hughes; M I Lorber; P W Askenase; J S Pober
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.